Activating mutations in c-KIT and PDGFRα are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes
Burger, Kk, den Bakker, Michael A., Kros, Johan M., de Bruin, Alex M., Oosterhuis, Walter, van den Ingh, Henry F.G.M., van der Harst, Erwin, de Schipper, Hans P., Wiemer, Erik A.C., Nooter, KeesVolume:
4
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.4.11.2253
Date:
November, 2005
File:
PDF, 521 KB
english, 2005